Germany to make J&J's COVID-19 vaccine available to all adults
Reuters
Published May 10, 2021 04:51AM ET
BERLIN (Reuters) - Germany is to make Johnson & Johnson (NYSE:JNJ)'s COVID-19 vaccine available to all adults, Health Minister Jens Spahn said on Monday, adding that they will be able to receive the shot on the advice of a doctor.
Europe's drug regulator backed J&J's vaccine last month after examining cases of a rare blood clotting issue in U.S. adults who received a dose. But it left it up to the European Union's member states to decide how to use it.
Germany's move to offer the J&J single-dose vaccine widely follows the lifting of restrictions last week on the AstraZeneca (NASDAQ:AZN) vaccine.
The AstraZeneca shot had been earmarked for people aged over 60 following similar reports of very rare but sometimes fatal clotting events in younger people, with women disproportionately affected.
The decisions reflect Germany's progress in vaccinating its seniors, Spahn said, adding he expected everyone aged 60 and above who wanted to be vaccinated to be offered a shot by late May or early June.
With millions of J&J doses due to arrive later in the second quarter of this year, it made sense to make the shot more widely available, he added.
Spahn forecast that 10 million doses of the J&J shot were expected to arrive in Germany by the end of the second quarter.
Get The News You Want
Written By: Reuters
Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.